𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Podocalyxin is a marker of poor prognosis in colorectal cancer

✍ Scribed by Tuomas Kaprio,Christian Fermér,Jaana Hagström,Harri Mustonen…

Book ID
126371250
Publisher
BioMed Central
Year
2014
Tongue
English
Weight
613 KB
Volume
14
Category
Article
ISSN
1471-2407

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SCRN1 is a novel marker for prognosis in
SCRN1 is a novel marker for prognosis in colorectal cancer
✍ Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Mitsugu Sekimoto; Yuichiro Doki; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## Purpose Secernin 1 (__SCRN1__) is a member of the secernin family and is reported to be a tumor‐associated antigen. Previous reports show that __SCRN1__ is upregulated in gastric cancer cell lines and may be a novel immunotherapy target, whereas its significance in colorectal cancer